Relugolix + E2/NETA

Indicaton

Heavy menstrual bleeding associated with uterine fibroids.

Therapeutic indications

Women’s health

Type of product

Small molecule

Table

Phase

Phase III completed

You may also be interested in

OligoPhore / SemaPhore Peptide-Based RNA Delivery Platforms

Delivers siRNA, antisense oligonucleotides, mRNA and other mRNA modalities to extrahepatic tissues - demonstrated across various indications in oncology (e.g. PDAC, breast cancer, ovarian cancer, lung cancer, melanoma, ATLL, TME), and inflammatory / autoimmune diseases (e.g. OA, RA, enterocolitis), CV (e.g. atherosclerosis, aortic aneurysm)

Discovery

Relugolix + E2/NETA

Endometriosis-associated pain.

Phase III started

PapilloDia

PapilloDia is an innovative rapid test for the detection of cervical pre-cancer and cancer in 15 minutes.

Marketed